LGM Pharma is a leading contract development and manufacturing organisation (CDMO) specialising in active pharmaceutical ingredient (API) sourcing and comprehensive drug product services for the pharmaceutical, biotechnology, and compounding pharmacy sectors.

With a legacy spanning nearly a century, LGM Pharma has evolved from a prominent API sourcing entity into a full-service CDMO. The company’s extensive global network of over 300 prequalified GMP-compliant API manufacturers ensures access to high-quality APIs, optimising supply chain management and mitigating risks. LGM Pharma’s U.S.-based facilities encompass more than 100,000 square feet dedicated to GMP research and development, pilot plant operations, and cGMP manufacturing, supporting projects from early R&D through to commercialisation.

Key Products and Services

API Sourcing: Leveraging strong relationships with world-class manufacturers globally, LGM Pharma reduces supply chain risks and improves access to high-quality APIs.

CDMO Services:

Formulation Development: Expertise in developing solid dose, liquid, semi-solid, and suppository formulations.
Manufacturing: Capabilities include production of solid dose delivery systems, liquids/suspensions, semi-solids, and suppositories, with facilities equipped for commercial scale-up.
Regulatory Management: In-house experts provide tailored regulatory strategies, assisting with CMC requirements and supporting ANDA and NDA submissions.

Analytical Services:

Analytical Testing: Comprehensive method development and validation services.
Stability Services: Robust stability studies to ensure product integrity throughout its lifecycle.

LGM Pharma’s commitment to quality, innovation, and customer-centric solutions positions it as a trusted partner in the pharmaceutical industry. By integrating API sourcing with end-to-end CDMO services, the company accelerates the path to market for clients, ensuring efficiency and compliance at every stage of the drug development process.